Search - tctmd.com

Displaying 41 - 60 of 169

Sort: Relevancy | Date

Presentation THT 2024

Introduction Of Guideline Directed Medical Therapy And Native Heart Recovery In Patients Supported By Impella 5.5

Presenter: Kanika P. Mody

March 06, 2024

Presentation THT Abstracts 2024

Outcomes of Impella 5.5 in Heart Failure-Related Cardiogenic Shock from the SURPASS (Surgical Unloading Renal Protection and Sustainable Support) Registry

Presenter: Jacob Abraham

March 05, 2024

Presentation THT Abstracts 2024

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Presenter: Justin Fried

March 05, 2024

Presentation THT Abstracts 2024

A Report from the Cardiogenic Shock Working Group on use of Impella 5.0/5.5 for Cardiogenic Shock and Successful Bridge to Recovery, durable LVAD or Heart Transplantation

Presenter: Maryjane Farr

March 05, 2024

Presentation THT 2024

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Presenter: Justin Fried

March 05, 2024

Presentation THT Abstracts 2024

Enhanced Cardiac Support and Reduced Risks: Evaluating Impella 5.5 in ECPELLA Therapy

Presenter: Ameesh Isath

March 04, 2024

Presentation THT Abstracts 2024

Assessment of patients with cardiogenic shock requiring veno-arterial extracorporeal membrane oxygenation upgrade from Impella 5.5 univentricular support

Presenter: James Schurr

March 04, 2024

News Daily News

New Risk Score Better for Capturing Medical Urgency for Heart Transplantation

Michael O'Riordan

February 19, 2024

Presentation CTO Plus 2024 Abstracts On-Demand 2024

Mechanical Circulatory Support for High-Risk Percutaneous Coronary Intervention with Impella CP versus Impella 5.5

Presenter: Samip Vasaiwala

February 02, 2024

News Conference News TCT 2023

Intermittent Coronary Sinus Occlusion Fails to Cut Infarct Size in STEMI

Yael L. Maxwell

November 06, 2023

Presentation TCT 2023

TCT 581: One-Year Outcomes in Non-Emergent Percutaneous Coronary Intervention Patients with Impella Support versus Intra-Aortic Balloon Pump

Presenter: George Vetrovec

October 26, 2023

News Daily News

FDA Scolds Abiomed for Not Seeking a PMA for Its Web-Based User Portal

Caitlin E. Cox

October 17, 2023

News Conference News ESC 2023

Routine ECMO in AMICS Patients Not Protective: ECLS-SHOCK

Caitlin E. Cox

August 26, 2023

News Daily News

FDA: Class I Recall for Left-Sided Impella Pumps Due to TAVI Interaction

Caitlin E. Cox

July 27, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2023

Shelley Wood

July 03, 2023

News Daily News

Medicare Data on AMICS Too Muddied for Firm Conclusions on Impella

Caitlin E. Cox

June 21, 2023

News Daily News

Abiomed Recalls Certain Impella 5.5 Devices Due to Risk of Purge-Fluid Leaks

Caitlin E. Cox

June 05, 2023

Presentation THT 2023

Influence of Body Surface Area, and Ventricular Dimensions on Impella 5.5 Outcomes

Presenter: Muath Bishawi

March 21, 2023

News Conference News THT 2023

PCI’s Role for Patients With HFrEF and Extensive CAD: Experts Debate

Todd Neale

March 20, 2023

Presentation THT 2023

Real-World Outcomes of Impella 5.5 in Patients with Cardiogenic Shock: Analysis of the SURPASS Registry

Presenter: Arman Kilic

March 20, 2023

Advertisement

Introduction Of Guideline Directed Medical Therapy And Native Heart Recovery In Patients Supported By Impella 5.5

Outcomes of Impella 5.5 in Heart Failure-Related Cardiogenic Shock from the SURPASS (Surgical Unloading Renal Protection and Sustainable Support) Registry

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

A Report from the Cardiogenic Shock Working Group on use of Impella 5.0/5.5 for Cardiogenic Shock and Successful Bridge to Recovery, durable LVAD or Heart Transplantation

Clinical Outcomes and Adverse Events in Cardiogenic Shock Patients who Recieved Impella 5.0/5.5: A Report from the Cardiogenic Shock Working Group

Enhanced Cardiac Support and Reduced Risks: Evaluating Impella 5.5 in ECPELLA Therapy

Assessment of patients with cardiogenic shock requiring veno-arterial extracorporeal membrane oxygenation upgrade from Impella 5.5 univentricular support

New Risk Score Better for Capturing Medical Urgency for Heart Transplantation

Mechanical Circulatory Support for High-Risk Percutaneous Coronary Intervention with Impella CP versus Impella 5.5

Intermittent Coronary Sinus Occlusion Fails to Cut Infarct Size in STEMI

TCT 581: One-Year Outcomes in Non-Emergent Percutaneous Coronary Intervention Patients with Impella Support versus Intra-Aortic Balloon Pump

FDA Scolds Abiomed for Not Seeking a PMA for Its Web-Based User Portal

Routine ECMO in AMICS Patients Not Protective: ECLS-SHOCK

FDA: Class I Recall for Left-Sided Impella Pumps Due to TAVI Interaction

TCTMD’s Top 10 Most Popular Stories for June 2023

Medicare Data on AMICS Too Muddied for Firm Conclusions on Impella

Abiomed Recalls Certain Impella 5.5 Devices Due to Risk of Purge-Fluid Leaks

Influence of Body Surface Area, and Ventricular Dimensions on Impella 5.5 Outcomes

PCI’s Role for Patients With HFrEF and Extensive CAD: Experts Debate

Real-World Outcomes of Impella 5.5 in Patients with Cardiogenic Shock: Analysis of the SURPASS Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content